79093385 - TG THROMBOGENICS

Information

• Trademark
• 79093385

• Source

• Serial Number

  79093385

• Registration Number

  4047607

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 30, 2010
  13 years ago

• Registration Date

  November 01, 2011
  12 years ago

• Transaction Date

  April 12, 2023
  a year ago

• Status Date

  May 13, 2022
  2 years ago

• Published for Opposition Date

  August 16, 2011
  13 years ago

• Location Date

  May 11, 2018
  6 years ago

• Status Code

  709

• Employee Name

  RUTLAND, BARBARA A

• Attorney Docket Number

  NO30163TUS

  Attorney Name

  Thomas J. Mango

  Law Office Assigned Location Code

  L10

• Owners

  • THROMBOGENICS NV

Case File Statements

• DM0000: The mark consists of the letters "TG" in grey and the word "thrombogenics" in red with a grey vertical line separating the literal elements of the mark.
• GS0051: Pharmaceutical preparations for treatment of diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; veterinary preparations for treatment of diseases and disorders in mammalians, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters; material for stopping teeth, dental wax; disinfectants for medical instruments, for hygienic purposes, and for use in medical surgery procedures; preparations for destroying vermin; fungicides, herbicides; biopharmaceutical preparations, namely, anticoagulants, anti angiogenic drugs, anticancer drugs, cardiovascular drugs, protease enzymes, protease inhibitors, antibodies, plasmins, truncated plasmins, microplasmins, plasminogens, truncated plasminogens, microplasminogens, plasminogen activators, staphylokinases for the treatment diseases and disorders, namely, ophthalmic and visual disorders, vascular and cardiovascular disorders, cardiac diseases, stroke, inflammation, hypertension, pulmonary hypertension, edema, immune system disorders, immune system related disorders, eye diseases, blood disorders, thrombotic diseases and cancer; diagnostic medical reagents, chemicals and biological materials, namely, antigen and diagnostic kits consisting primarily of monoclonal and/or polyclonal antibodies, buffers, and reagents for medical laboratory use in disease testing
• PM0000: TG THROMBO GENICS
• CC0000: The color(s) red and grey is/are claimed as a feature of the mark.
• GS0011: Chemical preparations and substances for use in the manufacture of pharmaceuticals
• GS0441: Medical services; veterinary services; medical, veterinary and pharmaceutical advisory and consultancy services; medical services, namely, therapeutic, prognostic and diagnostic testing services
• D10000: "THROMBOGENICS"
• GS0421: Scientific and technological services, namely, scientific research and design of new products in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention, and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; industrial analysis and product research services in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; pharmaceutical, biopharmaceutical, medical, biomedical, biological, biochemical, toxicological and clinical research and product development of diagnostic tests and kits, biopharmaceutical preparations and drugs, and medicines; biopharmaceutical product evaluation; biological, biochemical, pharmaceutical, medical, toxicological and clinical research, scientific research for medical purposes in the treatment of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer diseases and disorders; development services in the field of new biopharmaceutical drugs, preparations and medicines for ophthalmic, vascular and cancer pathologies

Case File Event Statements

• 4/11/2023 - a year ago

  40 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 3/1/2023 - a year ago

  39 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 3/1/2023 - a year ago

  38 - INVALIDATION PROCESSED Type: INPC

• 1/13/2023 - a year ago

  37 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 5/13/2022 - 2 years ago

  36 - CANCELLED SECTION 71 Type: C71T

• 12/17/2020 - 3 years ago

  35 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL

• 11/1/2020 - 3 years ago

  34 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4

• 6/13/2019 - 5 years ago

  33 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 3/8/2019 - 5 years ago

  32 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP

• 1/26/2019 - 5 years ago

  31 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS

• 1/26/2019 - 5 years ago

  30 - INVALIDATION PROCESSED Type: INPC

• 1/11/2019 - 5 years ago

  29 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR

• 9/28/2018 - 5 years ago

  28 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 5/11/2018 - 6 years ago

  27 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71

• 5/11/2018 - 6 years ago

  26 - REGISTERED - PARTIAL SEC 71 ACCEPTED Type: 71.P

• 5/11/2018 - 6 years ago

  25 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 5/1/2018 - 6 years ago

  24 - TEAS SECTION 71 RECEIVED Type: ES71

• 7/28/2012 - 12 years ago

  23 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 6/8/2012 - 12 years ago

  22 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 6/8/2012 - 12 years ago

  21 - FINAL DISPOSITION PROCESSED Type: FIMP

• 2/1/2012 - 12 years ago

  20 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 11/1/2011 - 12 years ago

  19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/16/2011 - 13 years ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/27/2011 - 13 years ago

  17 - NOTICE OF PUBLICATION Type: NPUB

• 7/13/2011 - 13 years ago

  16 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 7/12/2011 - 13 years ago

  15 - ASSIGNED TO LIE Type: ALIE

• 6/18/2011 - 13 years ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/17/2011 - 13 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/17/2011 - 13 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/17/2011 - 13 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/9/2011 - 13 years ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 3/22/2011 - 13 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 3/22/2011 - 13 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/19/2011 - 13 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/18/2011 - 13 years ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/12/2011 - 13 years ago

  5 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/8/2011 - 13 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 3/8/2011 - 13 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/4/2011 - 13 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 3/3/2011 - 13 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR